Know Cancer

or
forgot password

Genomics Evolution in Childhood Acute Lymphoblastic Leukemia


N/A
N/A
18 Years
Not Enrolling
Both
Acute Lymphoblastic Leukemia

Thank you

Trial Information

Genomics Evolution in Childhood Acute Lymphoblastic Leukemia


In order to know the genomic evolution of childhood acute lymphoblastic leukemia, we will
collect bone marrow (10c.c.) at diagnosis, remission and relapse. We will do the following
genes in addition to gene-chip including IKZF1,ETV6, EBF1, NR3C1, RAG1/G2, TCF3, BTLA,
PAX5,LEF1, ERG and VPREB1.We will study the gene dosages and degree of methylation. The
estimated patients numbers will be 300-400. Then we will correlate these data with
patients'age, white blood cell count at diagnosis, cytogenetic abnormalities, response to
the chemotherapy and prognosis.


Inclusion Criteria:



1. patients diagnosed as acute lymphoblastic leukemia

2. age less than or equal to 18 years old

3. signed informed consent

Exclusion Criteria:

1. who is not acute lymphoblastic leukemia

2. who did not sign informed consent

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Retrospective

Principal Investigator

Dong-Tsamn Lin, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

National Taiwan University Hospital,Taipei,Taiwan

Authority:

Taiwan: Department of Health

Study ID:

200906028R

NCT ID:

NCT01089907

Start Date:

April 2010

Completion Date:

June 2013

Related Keywords:

  • Acute Lymphoblastic Leukemia
  • genomic
  • childhood
  • acute lymphoblastic leukemia
  • Leukemia
  • Leukemia, Lymphoid
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma

Name

Location